APOLLO HOSPITALS ENTER. L vs Pharmaids Pharmaceuticals Ltd

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and Pharmaids Pharmaceuticals Ltd (PHARMAID) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs PHARMAID on 10 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth· not comparable
  • Size & financial health40

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

64.06
P/E ratio
0.00
12.55
P/B ratio
2.39
0.23%
Dividend yield
0.00%
₹135.04
EPS
₹-3.06

Profitability

APOLLOHOSP takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
-26.50%
18.00%
Return on capital
-17.43%
15.00%
EBITDA margin
-65.55%
7.94%
Net margin
-69.46%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y) even
33.39%
Profit CAGR (3Y) even

Size & financial health

APOLLOHOSP takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.24L Cr
Market cap
₹110 Cr
₹25,228 Cr
Revenue
₹19 Cr
₹2,003 Cr
Net profit
₹-14 Cr
0.32
Debt / equity
0.49
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Pharmaids Pharmaceuticals Ltd
  • + ["Company has reduced debt.", "Debtor days have improved from 56.1 to 44.9 days."]
  • ["Company has low interest coverage ratio.", "Promoter holding is low: 33.0%", "Company has a low return on equity of -19.4% over last 3 years."]
APOLLO HOSPITALS ENTER. L full analysis Pharmaids Pharmaceuticals Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.